| 1 | randomized | 134,424 |
| 2 | cluster-randomized | 697 |
| 3 | group-randomized | 115 |
| 4 | block-randomized | 43 |
| 5 | pseudo-randomized | 25 |
| 6 | prospective-randomized | 12 |
| 7 | block-randomised | 11 |
| 8 | randomized- | 7 |
| 9 | pre-randomized | 6 |
| 10 | aml96 | 4 |
| 11 | bgn | 4 |
| 12 | teapot | 4 |
| 13 | village-randomized | 4 |
| 14 | canada-wide | 3 |
| 15 | gcp-compliant | 3 |
| 16 | parallel-randomized | 3 |
| 17 | part-randomised | 3 |
| 18 | patient-randomised | 3 |
| 19 | radomized | 3 |
| 20 | +5.39 | 2 |
| 21 | -prospective | 2 |
| 22 | arriarán | 2 |
| 23 | crossover-diet | 2 |
| 24 | megestrol-controlled | 2 |
| 25 | nested-case | 2 |
| 26 | pla-controlled | 2 |
| 27 | sibling-oocyte | 2 |
| 28 | single-oven | 2 |
| 29 | sponsor-defined | 2 |
| 30 | tobacco-treatment | 2 |
| 31 | well-blinded | 2 |
| 32 | 'nasogastric | 1 |
| 33 | +/-history | 1 |
| 34 | +0.967 | 1 |
| 35 | +18.64 | 1 |
| 36 | -0.55±0.54 | 1 |
| 37 | -1.1±2.9 | 1 |
| 38 | -17.5/-8.8 | 1 |
| 39 | -2.5db | 1 |
| 40 | -2.81±0.85 | 1 |
| 41 | -3.8±7.3 | 1 |
| 42 | -33.9±0.8 | 1 |
| 43 | -42.5±0.8 | 1 |
| 44 | -5.3±0.9 | 1 |
| 45 | -810.1 | 1 |
| 46 | -9/-4 | 1 |
| 47 | .887 | 1 |
| 48 | 0* | 1 |
| 49 | 0.0+/-4.3 | 1 |
| 50 | 0.0004-0.024 | 1 |
| 51 | 0.01014 | 1 |
| 52 | 0.030/0.032 | 1 |
| 53 | 0.0430.028 | 1 |
| 54 | 0.046/0.047 | 1 |
| 55 | 0.06-21.4 | 1 |
| 56 | 0.06/0.25 | 1 |
| 57 | 0.060679 | 1 |
| 58 | 0.0726 | 1 |
| 59 | 0.0±1.62 | 1 |
| 60 | 0.1-15mg/l | 1 |
| 61 | 0.20+/-0.18 | 1 |
| 62 | 0.39-0.42 | 1 |
| 63 | 0.4028 | 1 |
| 64 | 0.49/0.16 | 1 |
| 65 | 0.495±0.027 | 1 |
| 66 | 0.564/h | 1 |
| 67 | 0.64+/-0.37 | 1 |
| 68 | 0.656-1.266 | 1 |
| 69 | 0.6914 | 1 |
| 70 | 0.71/0.45 | 1 |
| 71 | 0.7215 | 1 |
| 72 | 0.7554 | 1 |
| 73 | 0.9/1.1 | 1 |
| 74 | 0.9534 | 1 |
| 75 | 0.9593 | 1 |
| 76 | 0.97+/-0.004 | 1 |
| 77 | 0/+11 | 1 |
| 78 | 0·162 | 1 |
| 79 | 0·833 | 1 |
| 80 | 1.09-1.10 | 1 |
| 81 | 1.10±0.17 | 1 |
| 82 | 1.11±0.20 | 1 |
| 83 | 1.33+/-0.80 | 1 |
| 84 | 1.36mm | 1 |
| 85 | 1.428±0.068 | 1 |
| 86 | 1.554±0.53 | 1 |
| 87 | 1.79-1.89 | 1 |
| 88 | 1.88/1.57 | 1 |
| 89 | 10.12±0.058 | 1 |
| 90 | 10.530 | 1 |
| 91 | 102.5±0.6 | 1 |
| 92 | 102.7±20.1 | 1 |
| 93 | 102.9±42.2 | 1 |
| 94 | 104.39-125.76 | 1 |
| 95 | 11.79±6.42 | 1 |
| 96 | 1179.88 | 1 |
| 97 | 12+/-7 | 1 |
| 98 | 12-month-pilot | 1 |
| 99 | 12.806 | 1 |
| 100 | 120/71 | 1 |
| 101 | 125+/-16/76+/-7mmhg | 1 |
| 102 | 13.2±2.0 | 1 |
| 103 | 13.3+/-5.6 | 1 |
| 104 | 134-week | 1 |
| 105 | 136.82±46.38 | 1 |
| 106 | 14.2±7.6 | 1 |
| 107 | 14.7±2.0 | 1 |
| 108 | 140±21.9 | 1 |
| 109 | 16768 | 1 |
| 110 | 169/80 | 1 |
| 111 | 17.2+/-7.17 | 1 |
| 112 | 178.04 | 1 |
| 113 | 183.70 | 1 |
| 114 | 19,000-patient | 1 |
| 115 | 19.87+/-10.03 | 1 |
| 116 | 192.25±99.17 | 1 |
| 117 | 2'-carboxy-xlr-11 | 1 |
| 118 | 2.071 | 1 |
| 119 | 2.14±0.18 | 1 |
| 120 | 2.675 | 1 |
| 121 | 2.6±0.8 | 1 |
| 122 | 2.89+0.06 | 1 |
| 123 | 2.8mm | 1 |
| 124 | 2.98+/-1.05 | 1 |
| 125 | 20.5/1000 | 1 |
| 126 | 207.82 | 1 |
| 127 | 21.10±1.90 | 1 |
| 128 | 212+/-70 | 1 |
| 129 | 2156delginscc | 1 |
| 130 | 216.87 | 1 |
| 131 | 216·6 | 1 |
| 132 | 224.33 | 1 |
| 133 | 226.9 | 1 |
| 134 | 24,800 | 1 |
| 135 | 244.98 | 1 |
| 136 | 25,396 | 1 |
| 137 | 25.5±7.7 | 1 |
| 138 | 250n | 1 |
| 139 | 25:60:15 | 1 |
| 140 | 26.70±7.48 | 1 |
| 141 | 267.7 | 1 |
| 142 | 27+/-7 | 1 |
| 143 | 27.79 | 1 |
| 144 | 27·6:1 | 1 |
| 145 | 28.8° | 1 |
| 146 | 28°c/20°c | 1 |
| 147 | 29-center | 1 |
| 148 | 295+/-46 | 1 |
| 149 | 3.04±1.81 | 1 |
| 150 | 3.17±1.72 | 1 |
| 151 | 3.2mmol/l | 1 |
| 152 | 3.2±2.3 | 1 |
| 153 | 3.5-10.9 | 1 |
| 154 | 3.6±0.48 | 1 |
| 155 | 3.8+/-1.6 | 1 |
| 156 | 3.87:1 | 1 |
| 157 | 30.3/19.7 | 1 |
| 158 | 314/144 | 1 |
| 159 | 31423.4 | 1 |
| 160 | 32.15°c | 1 |
| 161 | 33.5±29.2 | 1 |
| 162 | 34.49°c | 1 |
| 163 | 34.9±0.3 | 1 |
| 164 | 354.0→191.8 | 1 |
| 165 | 361.29 | 1 |
| 166 | 36:7 | 1 |
| 167 | 37.7±0.3 | 1 |
| 168 | 381.60 | 1 |
| 169 | 394n | 1 |
| 170 | 4,022 | 1 |
| 171 | 4.35-5.4 | 1 |
| 172 | 4.4±2.9 | 1 |
| 173 | 4.69-/+1.29 | 1 |
| 174 | 4.7+/-2.1 | 1 |
| 175 | 4.87±0.69 | 1 |
| 176 | 43-1723 | 1 |
| 177 | 44/98 | 1 |
| 178 | 45.3+/-2.6 | 1 |
| 179 | 46.6-68.7 | 1 |
| 180 | 46.8±7.7 | 1 |
| 181 | 485.472mg/kg | 1 |
| 182 | 486.73 | 1 |
| 183 | 5,094 | 1 |
| 184 | 5,293 | 1 |
| 185 | 5,4'-dihydroxi-7-methoxyflavanone | 1 |
| 186 | 5,4′-dihydroxi-7-methoxyflavanone | 1 |
| 187 | 5.0±0.6 | 1 |
| 188 | 5.16-5.39 | 1 |
| 189 | 5.21±2.05 | 1 |
| 190 | 5.24±3.62 | 1 |
| 191 | 5.3microg/ml | 1 |
| 192 | 5.89e-03 | 1 |
| 193 | 51.35±12.21 | 1 |
| 194 | 518.5 | 1 |
| 195 | 53.3+/-3.7 | 1 |
| 196 | 54.66-98.59 | 1 |
| 197 | 55,854 | 1 |
| 198 | 56/min | 1 |
| 199 | 5665 | 1 |
| 200 | 57.4±9.8 | 1 |
| 201 | 58.30+/-4.37 | 1 |
| 202 | 6,10,14-trimethyl-2-pentadecanone | 1 |
| 203 | 6-minute-walk-test | 1 |
| 204 | 6.3-19 | 1 |
| 205 | 6.33±23.93 | 1 |
| 206 | 6.39+/-1.12 | 1 |
| 207 | 6.41° | 1 |
| 208 | 6.8±2.2 | 1 |
| 209 | 62.18 | 1 |
| 210 | 63.31 | 1 |
| 211 | 681n | 1 |
| 212 | 69,850 | 1 |
| 213 | 6971 | 1 |
| 214 | 7.1+/-1.5 | 1 |
| 215 | 7.5-15.4 | 1 |
| 216 | 7.5±2 | 1 |
| 217 | 70.11 | 1 |
| 218 | 74p | 1 |
| 219 | 788.70 | 1 |
| 220 | 8.0±2.6 | 1 |
| 221 | 82.11-98.91 | 1 |
| 222 | 876.77±97.34ng/ml | 1 |
| 223 | 9,181 | 1 |
| 224 | 9-fluorenone | 1 |
| 225 | 9.2+/-1.3 | 1 |
| 226 | 9.27±1.63 | 1 |
| 227 | 9.5-10.5 | 1 |
| 228 | 90.6±6.2 | 1 |
| 229 | 909.1 | 1 |
| 230 | 92.29 | 1 |
| 231 | 92.5-103.6 | 1 |
| 232 | 93- | 1 |
| 233 | 957-1004 | 1 |
| 234 | 96.5±1.3 | 1 |
| 235 | 97.3/91.3 | 1 |
| 236 | 97.6/99.2 | 1 |
| 237 | 970µg/ml | 1 |
| 238 | 99.2°±29.6° | 1 |
| 239 | a00-a09 | 1 |
| 240 | aed-free | 1 |
| 241 | albumin-dependent | 1 |
| 242 | antigen-primed | 1 |
| 243 | arkansas-positive | 1 |
| 244 | asyptomatic | 1 |
| 245 | auc=0.669 | 1 |
| 246 | bb-77 | 1 |
| 247 | behavior-cognitive | 1 |
| 248 | bladder-specific | 1 |
| 249 | bleeding/hemorrhage | 1 |
| 250 | breast-breast | 1 |
| 251 | breathalyzed | 1 |
| 252 | c-low/g-low | 1 |
| 253 | c.66_68delag | 1 |
| 254 | c16:1ω5t | 1 |
| 255 | cch-naïve | 1 |
| 256 | cefuroxime-resistant | 1 |
| 257 | certain/probable | 1 |
| 258 | chrysin-6-c-arabinosyl-8-c-glucoside | 1 |
| 259 | ck19+/vimentin+/p63+ | 1 |
| 260 | clinician-scored | 1 |
| 261 | cmax=175ng/ml | 1 |
| 262 | coarser-grained | 1 |
| 263 | colposcopist-related | 1 |
| 264 | condolomatosis | 1 |
| 265 | ct1c | 1 |
| 266 | current-smokers | 1 |
| 267 | d1mit169 | 1 |
| 268 | de-rotated | 1 |
| 269 | decatheterized | 1 |
| 270 | defined-normal | 1 |
| 271 | discussesed | 1 |
| 272 | dkk-3-positive | 1 |
| 273 | dose-defined | 1 |
| 274 | double-tailed | 1 |
| 275 | dysgeusia/ageusia | 1 |
| 276 | dyspnoea/breathlessness | 1 |
| 277 | e92q | 1 |
| 278 | ear-tagged | 1 |
| 279 | epa/18:1/18:1 | 1 |
| 280 | euro22,320 | 1 |
| 281 | euro2415 | 1 |
| 282 | euro262 | 1 |
| 283 | euro324 | 1 |
| 284 | fatty/oily/waxy | 1 |
| 285 | fdp-negative | 1 |
| 286 | fervescence | 1 |
| 287 | fistol | 1 |
| 288 | five-category | 1 |
| 289 | fj748766 | 1 |
| 290 | french-german | 1 |
| 291 | g349r/c.870delc | 1 |
| 292 | gel-purified | 1 |
| 293 | gfi=.93 | 1 |
| 294 | ginsenoside‑rg1 | 1 |
| 295 | gram-reaction-negative | 1 |
| 296 | heavy-users | 1 |
| 297 | hepatitis-c-positive | 1 |
| 298 | her1-positive | 1 |
| 299 | hikers | 1 |
| 300 | hla-dq2/dq8-positive | 1 |
| 301 | holter- | 1 |
| 302 | hpsa-negative | 1 |
| 303 | hyperferritinemic | 1 |
| 304 | identified-anchor | 1 |
| 305 | identified/developed | 1 |
| 306 | immuno-stained | 1 |
| 307 | improved/cured | 1 |
| 308 | inconsistent.one | 1 |
| 309 | iso-coupled | 1 |
| 310 | isonutritive | 1 |
| 311 | levamisole+oxfendazole | 1 |
| 312 | lower= | 1 |
| 313 | lp+m1 | 1 |
| 314 | machine-smoked | 1 |
| 315 | medication-randomized | 1 |
| 316 | meta-analyzable | 1 |
| 317 | microbiologically-guided | 1 |
| 318 | milestones-based | 1 |
| 319 | mini-helix | 1 |
| 320 | multi-methods | 1 |
| 321 | nachr-targeted | 1 |
| 322 | nationalized | 1 |
| 323 | nci-designated | 1 |
| 324 | nonco-operative | 1 |
| 325 | obstetric-anesthesia | 1 |
| 326 | open-comparative | 1 |
| 327 | p24-antigenaemic | 1 |
| 328 | pan-disease | 1 |
| 329 | papg+ | 1 |
| 330 | pcp-led | 1 |
| 331 | penicillin-non-susceptible | 1 |
| 332 | physiologic-like | 1 |
| 333 | pound7474 | 1 |
| 334 | power-brushed | 1 |
| 335 | predoment | 1 |
| 336 | psa-tested | 1 |
| 337 | qnrb1 | 1 |
| 338 | radiothyroidectomized | 1 |
| 339 | randomiazed | 1 |
| 340 | randomized/quasirandomized | 1 |
| 341 | re-anesthetized | 1 |
| 342 | re-look | 1 |
| 343 | re-sited | 1 |
| 344 | recatheterized | 1 |
| 345 | rpw-type | 1 |
| 346 | salmonellaspecies | 1 |
| 347 | sccmec-untypeable | 1 |
| 348 | seen.however | 1 |
| 349 | sequenced/mapped | 1 |
| 350 | sfn-glutathione | 1 |
| 351 | single-clinic | 1 |
| 352 | single/double-blind | 1 |
| 353 | spermiating | 1 |
| 354 | stain-negative | 1 |
| 355 | steam-inhalation | 1 |
| 356 | sumarized | 1 |
| 357 | symptom-centered | 1 |
| 358 | teetotal | 1 |
| 359 | thermal-cycled | 1 |
| 360 | toxicity-evaluable | 1 |
| 361 | trans-anetole | 1 |
| 362 | unclear.one | 1 |
| 363 | uncomplicated/transient | 1 |
| 364 | urticaria-angioedema | 1 |
| 365 | usa500 | 1 |
| 366 | usd31,663 | 1 |
| 367 | v179f | 1 |
| 368 | vitamins/megavitamins | 1 |
| 369 | wada-sponsored | 1 |
| 370 | well-depicted | 1 |
| 371 | xpd-751 | 1 |
| 372 | ~100:1 | 1 |
| 373 | ~129.7 | 1 |
| 374 | ~164 | 1 |
| 375 | £1366 | 1 |
| 376 | к=0.77 | 1 |
| 377 | €15,166 | 1 |
| 378 | €1752 | 1 |
| 379 | €2140 | 1 |
| 380 | €376 | 1 |
| 381 | €497 | 1 |
| 382 | €6269 | 1 |
| 383 | €658 | 1 |
| 384 | €680 | 1 |
| 385 | €9.85 | 1 |
| 1 | 'nasogastric | 1 |
| 2 | +/-history | 1 |
| 3 | +0.967 | 1 |
| 4 | +18.64 | 1 |
| 5 | +5.39 | 2 |
| 6 | -0.55±0.54 | 1 |
| 7 | -1.1±2.9 | 1 |
| 8 | -17.5/-8.8 | 1 |
| 9 | -2.5db | 1 |
| 10 | -2.81±0.85 | 1 |
| 11 | -3.8±7.3 | 1 |
| 12 | -33.9±0.8 | 1 |
| 13 | -42.5±0.8 | 1 |
| 14 | -5.3±0.9 | 1 |
| 15 | -810.1 | 1 |
| 16 | -9/-4 | 1 |
| 17 | -prospective | 2 |
| 18 | .887 | 1 |
| 19 | 0* | 1 |
| 20 | 0.0+/-4.3 | 1 |
| 21 | 0.0004-0.024 | 1 |
| 22 | 0.01014 | 1 |
| 23 | 0.030/0.032 | 1 |
| 24 | 0.0430.028 | 1 |
| 25 | 0.046/0.047 | 1 |
| 26 | 0.06-21.4 | 1 |
| 27 | 0.06/0.25 | 1 |
| 28 | 0.060679 | 1 |
| 29 | 0.0726 | 1 |
| 30 | 0.0±1.62 | 1 |
| 31 | 0.1-15mg/l | 1 |
| 32 | 0.20+/-0.18 | 1 |
| 33 | 0.39-0.42 | 1 |
| 34 | 0.4028 | 1 |
| 35 | 0.49/0.16 | 1 |
| 36 | 0.495±0.027 | 1 |
| 37 | 0.564/h | 1 |
| 38 | 0.64+/-0.37 | 1 |
| 39 | 0.656-1.266 | 1 |
| 40 | 0.6914 | 1 |
| 41 | 0.71/0.45 | 1 |
| 42 | 0.7215 | 1 |
| 43 | 0.7554 | 1 |
| 44 | 0.9/1.1 | 1 |
| 45 | 0.9534 | 1 |
| 46 | 0.9593 | 1 |
| 47 | 0.97+/-0.004 | 1 |
| 48 | 0/+11 | 1 |
| 49 | 0·162 | 1 |
| 50 | 0·833 | 1 |
| 51 | 1.09-1.10 | 1 |
| 52 | 1.10±0.17 | 1 |
| 53 | 1.11±0.20 | 1 |
| 54 | 1.33+/-0.80 | 1 |
| 55 | 1.36mm | 1 |
| 56 | 1.428±0.068 | 1 |
| 57 | 1.554±0.53 | 1 |
| 58 | 1.79-1.89 | 1 |
| 59 | 1.88/1.57 | 1 |
| 60 | 10.12±0.058 | 1 |
| 61 | 10.530 | 1 |
| 62 | 102.5±0.6 | 1 |
| 63 | 102.7±20.1 | 1 |
| 64 | 102.9±42.2 | 1 |
| 65 | 104.39-125.76 | 1 |
| 66 | 11.79±6.42 | 1 |
| 67 | 1179.88 | 1 |
| 68 | 12+/-7 | 1 |
| 69 | 12-month-pilot | 1 |
| 70 | 12.806 | 1 |
| 71 | 120/71 | 1 |
| 72 | 125+/-16/76+/-7mmhg | 1 |
| 73 | 13.2±2.0 | 1 |
| 74 | 13.3+/-5.6 | 1 |
| 75 | 134-week | 1 |
| 76 | 136.82±46.38 | 1 |
| 77 | 14.2±7.6 | 1 |
| 78 | 14.7±2.0 | 1 |
| 79 | 140±21.9 | 1 |
| 80 | 16768 | 1 |
| 81 | 169/80 | 1 |
| 82 | 17.2+/-7.17 | 1 |
| 83 | 178.04 | 1 |
| 84 | 183.70 | 1 |
| 85 | 19,000-patient | 1 |
| 86 | 19.87+/-10.03 | 1 |
| 87 | 192.25±99.17 | 1 |
| 88 | 2'-carboxy-xlr-11 | 1 |
| 89 | 2.071 | 1 |
| 90 | 2.14±0.18 | 1 |
| 91 | 2.675 | 1 |
| 92 | 2.6±0.8 | 1 |
| 93 | 2.89+0.06 | 1 |
| 94 | 2.8mm | 1 |
| 95 | 2.98+/-1.05 | 1 |
| 96 | 20.5/1000 | 1 |
| 97 | 207.82 | 1 |
| 98 | 21.10±1.90 | 1 |
| 99 | 212+/-70 | 1 |
| 100 | 2156delginscc | 1 |
| 101 | 216.87 | 1 |
| 102 | 216·6 | 1 |
| 103 | 224.33 | 1 |
| 104 | 226.9 | 1 |
| 105 | 24,800 | 1 |
| 106 | 244.98 | 1 |
| 107 | 25,396 | 1 |
| 108 | 25.5±7.7 | 1 |
| 109 | 250n | 1 |
| 110 | 25:60:15 | 1 |
| 111 | 26.70±7.48 | 1 |
| 112 | 267.7 | 1 |
| 113 | 27+/-7 | 1 |
| 114 | 27.79 | 1 |
| 115 | 27·6:1 | 1 |
| 116 | 28.8° | 1 |
| 117 | 28°c/20°c | 1 |
| 118 | 29-center | 1 |
| 119 | 295+/-46 | 1 |
| 120 | 3.04±1.81 | 1 |
| 121 | 3.17±1.72 | 1 |
| 122 | 3.2mmol/l | 1 |
| 123 | 3.2±2.3 | 1 |
| 124 | 3.5-10.9 | 1 |
| 125 | 3.6±0.48 | 1 |
| 126 | 3.8+/-1.6 | 1 |
| 127 | 3.87:1 | 1 |
| 128 | 30.3/19.7 | 1 |
| 129 | 314/144 | 1 |
| 130 | 31423.4 | 1 |
| 131 | 32.15°c | 1 |
| 132 | 33.5±29.2 | 1 |
| 133 | 34.49°c | 1 |
| 134 | 34.9±0.3 | 1 |
| 135 | 354.0→191.8 | 1 |
| 136 | 361.29 | 1 |
| 137 | 36:7 | 1 |
| 138 | 37.7±0.3 | 1 |
| 139 | 381.60 | 1 |
| 140 | 394n | 1 |
| 141 | 4,022 | 1 |
| 142 | 4.35-5.4 | 1 |
| 143 | 4.4±2.9 | 1 |
| 144 | 4.69-/+1.29 | 1 |
| 145 | 4.7+/-2.1 | 1 |
| 146 | 4.87±0.69 | 1 |
| 147 | 43-1723 | 1 |
| 148 | 44/98 | 1 |
| 149 | 45.3+/-2.6 | 1 |
| 150 | 46.6-68.7 | 1 |
| 151 | 46.8±7.7 | 1 |
| 152 | 485.472mg/kg | 1 |
| 153 | 486.73 | 1 |
| 154 | 5,094 | 1 |
| 155 | 5,293 | 1 |
| 156 | 5,4'-dihydroxi-7-methoxyflavanone | 1 |
| 157 | 5,4′-dihydroxi-7-methoxyflavanone | 1 |
| 158 | 5.0±0.6 | 1 |
| 159 | 5.16-5.39 | 1 |
| 160 | 5.21±2.05 | 1 |
| 161 | 5.24±3.62 | 1 |
| 162 | 5.3microg/ml | 1 |
| 163 | 5.89e-03 | 1 |
| 164 | 51.35±12.21 | 1 |
| 165 | 518.5 | 1 |
| 166 | 53.3+/-3.7 | 1 |
| 167 | 54.66-98.59 | 1 |
| 168 | 55,854 | 1 |
| 169 | 56/min | 1 |
| 170 | 5665 | 1 |
| 171 | 57.4±9.8 | 1 |
| 172 | 58.30+/-4.37 | 1 |
| 173 | 6,10,14-trimethyl-2-pentadecanone | 1 |
| 174 | 6-minute-walk-test | 1 |
| 175 | 6.3-19 | 1 |
| 176 | 6.33±23.93 | 1 |
| 177 | 6.39+/-1.12 | 1 |
| 178 | 6.41° | 1 |
| 179 | 6.8±2.2 | 1 |
| 180 | 62.18 | 1 |
| 181 | 63.31 | 1 |
| 182 | 681n | 1 |
| 183 | 69,850 | 1 |
| 184 | 6971 | 1 |
| 185 | 7.1+/-1.5 | 1 |
| 186 | 7.5-15.4 | 1 |
| 187 | 7.5±2 | 1 |
| 188 | 70.11 | 1 |
| 189 | 74p | 1 |
| 190 | 788.70 | 1 |
| 191 | 8.0±2.6 | 1 |
| 192 | 82.11-98.91 | 1 |
| 193 | 876.77±97.34ng/ml | 1 |
| 194 | 9,181 | 1 |
| 195 | 9-fluorenone | 1 |
| 196 | 9.2+/-1.3 | 1 |
| 197 | 9.27±1.63 | 1 |
| 198 | 9.5-10.5 | 1 |
| 199 | 90.6±6.2 | 1 |
| 200 | 909.1 | 1 |
| 201 | 92.29 | 1 |
| 202 | 92.5-103.6 | 1 |
| 203 | 93- | 1 |
| 204 | 957-1004 | 1 |
| 205 | 96.5±1.3 | 1 |
| 206 | 97.3/91.3 | 1 |
| 207 | 97.6/99.2 | 1 |
| 208 | 970µg/ml | 1 |
| 209 | 99.2°±29.6° | 1 |
| 210 | a00-a09 | 1 |
| 211 | aed-free | 1 |
| 212 | albumin-dependent | 1 |
| 213 | aml96 | 4 |
| 214 | antigen-primed | 1 |
| 215 | arkansas-positive | 1 |
| 216 | arriarán | 2 |
| 217 | asyptomatic | 1 |
| 218 | auc=0.669 | 1 |
| 219 | bb-77 | 1 |
| 220 | behavior-cognitive | 1 |
| 221 | bgn | 4 |
| 222 | bladder-specific | 1 |
| 223 | bleeding/hemorrhage | 1 |
| 224 | block-randomised | 11 |
| 225 | block-randomized | 43 |
| 226 | breast-breast | 1 |
| 227 | breathalyzed | 1 |
| 228 | c-low/g-low | 1 |
| 229 | c.66_68delag | 1 |
| 230 | c16:1ω5t | 1 |
| 231 | canada-wide | 3 |
| 232 | cch-naïve | 1 |
| 233 | cefuroxime-resistant | 1 |
| 234 | certain/probable | 1 |
| 235 | chrysin-6-c-arabinosyl-8-c-glucoside | 1 |
| 236 | ck19+/vimentin+/p63+ | 1 |
| 237 | clinician-scored | 1 |
| 238 | cluster-randomized | 697 |
| 239 | cmax=175ng/ml | 1 |
| 240 | coarser-grained | 1 |
| 241 | colposcopist-related | 1 |
| 242 | condolomatosis | 1 |
| 243 | crossover-diet | 2 |
| 244 | ct1c | 1 |
| 245 | current-smokers | 1 |
| 246 | d1mit169 | 1 |
| 247 | de-rotated | 1 |
| 248 | decatheterized | 1 |
| 249 | defined-normal | 1 |
| 250 | discussesed | 1 |
| 251 | dkk-3-positive | 1 |
| 252 | dose-defined | 1 |
| 253 | double-tailed | 1 |
| 254 | dysgeusia/ageusia | 1 |
| 255 | dyspnoea/breathlessness | 1 |
| 256 | e92q | 1 |
| 257 | ear-tagged | 1 |
| 258 | epa/18:1/18:1 | 1 |
| 259 | euro22,320 | 1 |
| 260 | euro2415 | 1 |
| 261 | euro262 | 1 |
| 262 | euro324 | 1 |
| 263 | fatty/oily/waxy | 1 |
| 264 | fdp-negative | 1 |
| 265 | fervescence | 1 |
| 266 | fistol | 1 |
| 267 | five-category | 1 |
| 268 | fj748766 | 1 |
| 269 | french-german | 1 |
| 270 | g349r/c.870delc | 1 |
| 271 | gcp-compliant | 3 |
| 272 | gel-purified | 1 |
| 273 | gfi=.93 | 1 |
| 274 | ginsenoside‑rg1 | 1 |
| 275 | gram-reaction-negative | 1 |
| 276 | group-randomized | 115 |
| 277 | heavy-users | 1 |
| 278 | hepatitis-c-positive | 1 |
| 279 | her1-positive | 1 |
| 280 | hikers | 1 |
| 281 | hla-dq2/dq8-positive | 1 |
| 282 | holter- | 1 |
| 283 | hpsa-negative | 1 |
| 284 | hyperferritinemic | 1 |
| 285 | identified-anchor | 1 |
| 286 | identified/developed | 1 |
| 287 | immuno-stained | 1 |
| 288 | improved/cured | 1 |
| 289 | inconsistent.one | 1 |
| 290 | iso-coupled | 1 |
| 291 | isonutritive | 1 |
| 292 | levamisole+oxfendazole | 1 |
| 293 | lower= | 1 |
| 294 | lp+m1 | 1 |
| 295 | machine-smoked | 1 |
| 296 | medication-randomized | 1 |
| 297 | megestrol-controlled | 2 |
| 298 | meta-analyzable | 1 |
| 299 | microbiologically-guided | 1 |
| 300 | milestones-based | 1 |
| 301 | mini-helix | 1 |
| 302 | multi-methods | 1 |
| 303 | nachr-targeted | 1 |
| 304 | nationalized | 1 |
| 305 | nci-designated | 1 |
| 306 | nested-case | 2 |
| 307 | nonco-operative | 1 |
| 308 | obstetric-anesthesia | 1 |
| 309 | open-comparative | 1 |
| 310 | p24-antigenaemic | 1 |
| 311 | pan-disease | 1 |
| 312 | papg+ | 1 |
| 313 | parallel-randomized | 3 |
| 314 | part-randomised | 3 |
| 315 | patient-randomised | 3 |
| 316 | pcp-led | 1 |
| 317 | penicillin-non-susceptible | 1 |
| 318 | physiologic-like | 1 |
| 319 | pla-controlled | 2 |
| 320 | pound7474 | 1 |
| 321 | power-brushed | 1 |
| 322 | pre-randomized | 6 |
| 323 | predoment | 1 |
| 324 | prospective-randomized | 12 |
| 325 | psa-tested | 1 |
| 326 | pseudo-randomized | 25 |
| 327 | qnrb1 | 1 |
| 328 | radiothyroidectomized | 1 |
| 329 | radomized | 3 |
| 330 | randomiazed | 1 |
| 331 | randomized | 134,424 |
| 332 | randomized- | 7 |
| 333 | randomized/quasirandomized | 1 |
| 334 | re-anesthetized | 1 |
| 335 | re-look | 1 |
| 336 | re-sited | 1 |
| 337 | recatheterized | 1 |
| 338 | rpw-type | 1 |
| 339 | salmonellaspecies | 1 |
| 340 | sccmec-untypeable | 1 |
| 341 | seen.however | 1 |
| 342 | sequenced/mapped | 1 |
| 343 | sfn-glutathione | 1 |
| 344 | sibling-oocyte | 2 |
| 345 | single-clinic | 1 |
| 346 | single-oven | 2 |
| 347 | single/double-blind | 1 |
| 348 | spermiating | 1 |
| 349 | sponsor-defined | 2 |
| 350 | stain-negative | 1 |
| 351 | steam-inhalation | 1 |
| 352 | sumarized | 1 |
| 353 | symptom-centered | 1 |
| 354 | teapot | 4 |
| 355 | teetotal | 1 |
| 356 | thermal-cycled | 1 |
| 357 | tobacco-treatment | 2 |
| 358 | toxicity-evaluable | 1 |
| 359 | trans-anetole | 1 |
| 360 | unclear.one | 1 |
| 361 | uncomplicated/transient | 1 |
| 362 | urticaria-angioedema | 1 |
| 363 | usa500 | 1 |
| 364 | usd31,663 | 1 |
| 365 | v179f | 1 |
| 366 | village-randomized | 4 |
| 367 | vitamins/megavitamins | 1 |
| 368 | wada-sponsored | 1 |
| 369 | well-blinded | 2 |
| 370 | well-depicted | 1 |
| 371 | xpd-751 | 1 |
| 372 | ~100:1 | 1 |
| 373 | ~129.7 | 1 |
| 374 | ~164 | 1 |
| 375 | £1366 | 1 |
| 376 | к=0.77 | 1 |
| 377 | €15,166 | 1 |
| 378 | €1752 | 1 |
| 379 | €2140 | 1 |
| 380 | €376 | 1 |
| 381 | €497 | 1 |
| 382 | €6269 | 1 |
| 383 | €658 | 1 |
| 384 | €680 | 1 |
| 385 | €9.85 | 1 |
| 1 | 0* | 1 |
| 2 | ck19+/vimentin+/p63+ | 1 |
| 3 | papg+ | 1 |
| 4 | 93- | 1 |
| 5 | randomized- | 7 |
| 6 | holter- | 1 |
| 7 | 13.2±2.0 | 1 |
| 8 | 14.7±2.0 | 1 |
| 9 | 20.5/1000 | 1 |
| 10 | usa500 | 1 |
| 11 | 24,800 | 1 |
| 12 | 1.09-1.10 | 1 |
| 13 | 1.11±0.20 | 1 |
| 14 | euro22,320 | 1 |
| 15 | 10.530 | 1 |
| 16 | €2140 | 1 |
| 17 | 69,850 | 1 |
| 18 | 381.60 | 1 |
| 19 | 212+/-70 | 1 |
| 20 | 183.70 | 1 |
| 21 | 788.70 | 1 |
| 22 | 1.33+/-0.80 | 1 |
| 23 | 169/80 | 1 |
| 24 | €680 | 1 |
| 25 | 21.10±1.90 | 1 |
| 26 | -810.1 | 1 |
| 27 | 102.7±20.1 | 1 |
| 28 | 0.9/1.1 | 1 |
| 29 | 4.7+/-2.1 | 1 |
| 30 | 909.1 | 1 |
| 31 | 0/+11 | 1 |
| 32 | 2'-carboxy-xlr-11 | 1 |
| 33 | 70.11 | 1 |
| 34 | 51.35±12.21 | 1 |
| 35 | 63.31 | 1 |
| 36 | xpd-751 | 1 |
| 37 | 120/71 | 1 |
| 38 | 2.071 | 1 |
| 39 | 6971 | 1 |
| 40 | 3.04±1.81 | 1 |
| 41 | 9,181 | 1 |
| 42 | 82.11-98.91 | 1 |
| 43 | ~100:1 | 1 |
| 44 | 27·6:1 | 1 |
| 45 | 3.87:1 | 1 |
| 46 | epa/18:1/18:1 | 1 |
| 47 | qnrb1 | 1 |
| 48 | ginsenoside‑rg1 | 1 |
| 49 | lp+m1 | 1 |
| 50 | 102.9±42.2 | 1 |
| 51 | 6.8±2.2 | 1 |
| 52 | 90.6±6.2 | 1 |
| 53 | 33.5±29.2 | 1 |
| 54 | 97.6/99.2 | 1 |
| 55 | 6.39+/-1.12 | 1 |
| 56 | 4,022 | 1 |
| 57 | 0.030/0.032 | 1 |
| 58 | 0.39-0.42 | 1 |
| 59 | 11.79±6.42 | 1 |
| 60 | €1752 | 1 |
| 61 | 0.0±1.62 | 1 |
| 62 | 5.24±3.62 | 1 |
| 63 | 0·162 | 1 |
| 64 | euro262 | 1 |
| 65 | 3.17±1.72 | 1 |
| 66 | 207.82 | 1 |
| 67 | 7.5±2 | 1 |
| 68 | 37.7±0.3 | 1 |
| 69 | 34.9±0.3 | 1 |
| 70 | 9.2+/-1.3 | 1 |
| 71 | 97.3/91.3 | 1 |
| 72 | 96.5±1.3 | 1 |
| 73 | 3.2±2.3 | 1 |
| 74 | 0.0+/-4.3 | 1 |
| 75 | -3.8±7.3 | 1 |
| 76 | 5.89e-03 | 1 |
| 77 | 19.87+/-10.03 | 1 |
| 78 | 43-1723 | 1 |
| 79 | 224.33 | 1 |
| 80 | 0·833 | 1 |
| 81 | 1.554±0.53 | 1 |
| 82 | 9.27±1.63 | 1 |
| 83 | usd31,663 | 1 |
| 84 | 486.73 | 1 |
| 85 | 6.33±23.93 | 1 |
| 86 | gfi=.93 | 1 |
| 87 | 5,293 | 1 |
| 88 | 0.9593 | 1 |
| 89 | -9/-4 | 1 |
| 90 | 0.06-21.4 | 1 |
| 91 | 31423.4 | 1 |
| 92 | 4.35-5.4 | 1 |
| 93 | 7.5-15.4 | 1 |
| 94 | 178.04 | 1 |
| 95 | 0.97+/-0.004 | 1 |
| 96 | 957-1004 | 1 |
| 97 | 0.01014 | 1 |
| 98 | 0.6914 | 1 |
| 99 | 0.0004-0.024 | 1 |
| 100 | euro324 | 1 |
| 101 | 0.9534 | 1 |
| 102 | 314/144 | 1 |
| 103 | -0.55±0.54 | 1 |
| 104 | 0.7554 | 1 |
| 105 | 55,854 | 1 |
| 106 | +18.64 | 1 |
| 107 | ~164 | 1 |
| 108 | pound7474 | 1 |
| 109 | 5,094 | 1 |
| 110 | 9.5-10.5 | 1 |
| 111 | 7.1+/-1.5 | 1 |
| 112 | 518.5 | 1 |
| 113 | 2.98+/-1.05 | 1 |
| 114 | 5.21±2.05 | 1 |
| 115 | 0.7215 | 1 |
| 116 | euro2415 | 1 |
| 117 | 25:60:15 | 1 |
| 118 | 0.06/0.25 | 1 |
| 119 | 0.71/0.45 | 1 |
| 120 | 5665 | 1 |
| 121 | 2.675 | 1 |
| 122 | -2.81±0.85 | 1 |
| 123 | €9.85 | 1 |
| 124 | 5.0±0.6 | 1 |
| 125 | 102.5±0.6 | 1 |
| 126 | 3.8+/-1.6 | 1 |
| 127 | 45.3+/-2.6 | 1 |
| 128 | 8.0±2.6 | 1 |
| 129 | 92.5-103.6 | 1 |
| 130 | 13.3+/-5.6 | 1 |
| 131 | 14.2±7.6 | 1 |
| 132 | 2.89+0.06 | 1 |
| 133 | 12.806 | 1 |
| 134 | 0.49/0.16 | 1 |
| 135 | 0.0726 | 1 |
| 136 | 295+/-46 | 1 |
| 137 | €15,166 | 1 |
| 138 | 0.656-1.266 | 1 |
| 139 | £1366 | 1 |
| 140 | fj748766 | 1 |
| 141 | 104.39-125.76 | 1 |
| 142 | €376 | 1 |
| 143 | 25,396 | 1 |
| 144 | aml96 | 4 |
| 145 | 216·6 | 1 |
| 146 | 12+/-7 | 1 |
| 147 | 27+/-7 | 1 |
| 148 | 53.3+/-3.7 | 1 |
| 149 | 267.7 | 1 |
| 150 | 25.5±7.7 | 1 |
| 151 | 46.8±7.7 | 1 |
| 152 | 46.6-68.7 | 1 |
| 153 | 30.3/19.7 | 1 |
| 154 | ~129.7 | 1 |
| 155 | 1.10±0.17 | 1 |
| 156 | 17.2+/-7.17 | 1 |
| 157 | 192.25±99.17 | 1 |
| 158 | 0.495±0.027 | 1 |
| 159 | 0.64+/-0.37 | 1 |
| 160 | 58.30+/-4.37 | 1 |
| 161 | 0.046/0.047 | 1 |
| 162 | 1.88/1.57 | 1 |
| 163 | +0.967 | 1 |
| 164 | bb-77 | 1 |
| 165 | к=0.77 | 1 |
| 166 | 216.87 | 1 |
| 167 | .887 | 1 |
| 168 | €497 | 1 |
| 169 | 36:7 | 1 |
| 170 | -42.5±0.8 | 1 |
| 171 | 2.6±0.8 | 1 |
| 172 | -33.9±0.8 | 1 |
| 173 | 354.0→191.8 | 1 |
| 174 | -17.5/-8.8 | 1 |
| 175 | 57.4±9.8 | 1 |
| 176 | 0.20+/-0.18 | 1 |
| 177 | 2.14±0.18 | 1 |
| 178 | 62.18 | 1 |
| 179 | 0.0430.028 | 1 |
| 180 | 0.4028 | 1 |
| 181 | 136.82±46.38 | 1 |
| 182 | 3.6±0.48 | 1 |
| 183 | 26.70±7.48 | 1 |
| 184 | 10.12±0.058 | 1 |
| 185 | €658 | 1 |
| 186 | 1.428±0.068 | 1 |
| 187 | 16768 | 1 |
| 188 | 1179.88 | 1 |
| 189 | 244.98 | 1 |
| 190 | 44/98 | 1 |
| 191 | 3.5-10.9 | 1 |
| 192 | -5.3±0.9 | 1 |
| 193 | 140±21.9 | 1 |
| 194 | -1.1±2.9 | 1 |
| 195 | 4.4±2.9 | 1 |
| 196 | 226.9 | 1 |
| 197 | a00-a09 | 1 |
| 198 | 6.3-19 | 1 |
| 199 | 4.69-/+1.29 | 1 |
| 200 | 361.29 | 1 |
| 201 | 92.29 | 1 |
| 202 | +5.39 | 2 |
| 203 | 5.16-5.39 | 1 |
| 204 | 54.66-98.59 | 1 |
| 205 | 4.87±0.69 | 1 |
| 206 | d1mit169 | 1 |
| 207 | €6269 | 1 |
| 208 | auc=0.669 | 1 |
| 209 | 27.79 | 1 |
| 210 | 0.060679 | 1 |
| 211 | 1.79-1.89 | 1 |
| 212 | lower= | 1 |
| 213 | obstetric-anesthesia | 1 |
| 214 | dysgeusia/ageusia | 1 |
| 215 | urticaria-angioedema | 1 |
| 216 | -2.5db | 1 |
| 217 | ct1c | 1 |
| 218 | 2156delginscc | 1 |
| 219 | bladder-specific | 1 |
| 220 | p24-antigenaemic | 1 |
| 221 | hyperferritinemic | 1 |
| 222 | single-clinic | 1 |
| 223 | 'nasogastric | 1 |
| 224 | asyptomatic | 1 |
| 225 | g349r/c.870delc | 1 |
| 226 | 28°c/20°c | 1 |
| 227 | 32.15°c | 1 |
| 228 | 34.49°c | 1 |
| 229 | microbiologically-guided | 1 |
| 230 | well-blinded | 2 |
| 231 | ear-tagged | 1 |
| 232 | power-brushed | 1 |
| 233 | gel-purified | 1 |
| 234 | machine-smoked | 1 |
| 235 | pcp-led | 1 |
| 236 | thermal-cycled | 1 |
| 237 | double-tailed | 1 |
| 238 | pla-controlled | 2 |
| 239 | megestrol-controlled | 2 |
| 240 | iso-coupled | 1 |
| 241 | antigen-primed | 1 |
| 242 | coarser-grained | 1 |
| 243 | immuno-stained | 1 |
| 244 | dose-defined | 1 |
| 245 | sponsor-defined | 2 |
| 246 | identified/developed | 1 |
| 247 | sequenced/mapped | 1 |
| 248 | symptom-centered | 1 |
| 249 | clinician-scored | 1 |
| 250 | wada-sponsored | 1 |
| 251 | improved/cured | 1 |
| 252 | milestones-based | 1 |
| 253 | discussesed | 1 |
| 254 | block-randomised | 11 |
| 255 | patient-randomised | 3 |
| 256 | part-randomised | 3 |
| 257 | colposcopist-related | 1 |
| 258 | nci-designated | 1 |
| 259 | de-rotated | 1 |
| 260 | well-depicted | 1 |
| 261 | nachr-targeted | 1 |
| 262 | re-sited | 1 |
| 263 | psa-tested | 1 |
| 264 | randomiazed | 1 |
| 265 | nationalized | 1 |
| 266 | radomized | 3 |
| 267 | randomized | 134,424 |
| 268 | village-randomized | 4 |
| 269 | pre-randomized | 6 |
| 270 | prospective-randomized | 12 |
| 271 | block-randomized | 43 |
| 272 | parallel-randomized | 3 |
| 273 | medication-randomized | 1 |
| 274 | pseudo-randomized | 25 |
| 275 | group-randomized | 115 |
| 276 | cluster-randomized | 697 |
| 277 | randomized/quasirandomized | 1 |
| 278 | radiothyroidectomized | 1 |
| 279 | sumarized | 1 |
| 280 | decatheterized | 1 |
| 281 | recatheterized | 1 |
| 282 | re-anesthetized | 1 |
| 283 | breathalyzed | 1 |
| 284 | single/double-blind | 1 |
| 285 | fervescence | 1 |
| 286 | chrysin-6-c-arabinosyl-8-c-glucoside | 1 |
| 287 | canada-wide | 3 |
| 288 | aed-free | 1 |
| 289 | bleeding/hemorrhage | 1 |
| 290 | physiologic-like | 1 |
| 291 | certain/probable | 1 |
| 292 | sccmec-untypeable | 1 |
| 293 | toxicity-evaluable | 1 |
| 294 | meta-analyzable | 1 |
| 295 | penicillin-non-susceptible | 1 |
| 296 | trans-anetole | 1 |
| 297 | levamisole+oxfendazole | 1 |
| 298 | unclear.one | 1 |
| 299 | inconsistent.one | 1 |
| 300 | sfn-glutathione | 1 |
| 301 | 6,10,14-trimethyl-2-pentadecanone | 1 |
| 302 | 5,4'-dihydroxi-7-methoxyflavanone | 1 |
| 303 | 5,4′-dihydroxi-7-methoxyflavanone | 1 |
| 304 | 9-fluorenone | 1 |
| 305 | rpw-type | 1 |
| 306 | nested-case | 2 |
| 307 | pan-disease | 1 |
| 308 | sibling-oocyte | 2 |
| 309 | hpsa-negative | 1 |
| 310 | stain-negative | 1 |
| 311 | gram-reaction-negative | 1 |
| 312 | fdp-negative | 1 |
| 313 | open-comparative | 1 |
| 314 | nonco-operative | 1 |
| 315 | -prospective | 2 |
| 316 | behavior-cognitive | 1 |
| 317 | isonutritive | 1 |
| 318 | her1-positive | 1 |
| 319 | dkk-3-positive | 1 |
| 320 | hla-dq2/dq8-positive | 1 |
| 321 | hepatitis-c-positive | 1 |
| 322 | arkansas-positive | 1 |
| 323 | cch-naïve | 1 |
| 324 | v179f | 1 |
| 325 | c.66_68delag | 1 |
| 326 | 125+/-16/76+/-7mmhg | 1 |
| 327 | 485.472mg/kg | 1 |
| 328 | spermiating | 1 |
| 329 | 0.564/h | 1 |
| 330 | 134-week | 1 |
| 331 | re-look | 1 |
| 332 | 0.1-15mg/l | 1 |
| 333 | 3.2mmol/l | 1 |
| 334 | defined-normal | 1 |
| 335 | teetotal | 1 |
| 336 | 876.77±97.34ng/ml | 1 |
| 337 | cmax=175ng/ml | 1 |
| 338 | 5.3microg/ml | 1 |
| 339 | 970µg/ml | 1 |
| 340 | fistol | 1 |
| 341 | 1.36mm | 1 |
| 342 | 2.8mm | 1 |
| 343 | 250n | 1 |
| 344 | 681n | 1 |
| 345 | 394n | 1 |
| 346 | french-german | 1 |
| 347 | single-oven | 2 |
| 348 | bgn | 4 |
| 349 | 56/min | 1 |
| 350 | steam-inhalation | 1 |
| 351 | arriarán | 2 |
| 352 | 74p | 1 |
| 353 | e92q | 1 |
| 354 | 29-center | 1 |
| 355 | seen.however | 1 |
| 356 | identified-anchor | 1 |
| 357 | multi-methods | 1 |
| 358 | salmonellaspecies | 1 |
| 359 | condolomatosis | 1 |
| 360 | vitamins/megavitamins | 1 |
| 361 | hikers | 1 |
| 362 | current-smokers | 1 |
| 363 | heavy-users | 1 |
| 364 | dyspnoea/breathlessness | 1 |
| 365 | c16:1ω5t | 1 |
| 366 | crossover-diet | 2 |
| 367 | gcp-compliant | 3 |
| 368 | cefuroxime-resistant | 1 |
| 369 | albumin-dependent | 1 |
| 370 | uncomplicated/transient | 1 |
| 371 | 19,000-patient | 1 |
| 372 | predoment | 1 |
| 373 | tobacco-treatment | 2 |
| 374 | 12-month-pilot | 1 |
| 375 | teapot | 4 |
| 376 | breast-breast | 1 |
| 377 | 6-minute-walk-test | 1 |
| 378 | c-low/g-low | 1 |
| 379 | mini-helix | 1 |
| 380 | five-category | 1 |
| 381 | +/-history | 1 |
| 382 | fatty/oily/waxy | 1 |
| 383 | 6.41° | 1 |
| 384 | 99.2°±29.6° | 1 |
| 385 | 28.8° | 1 |